Tag: Atara Biotherapeutics

Executives and investors in Thousand Oaks-based immunotherapy company Atara Biotherapeutics Inc. were left reeling last week after the U.S. Food and Drug Administration unexpectedly rejected the company’s lead…

Read more FDA Again Rejects Atara – Los Angeles Business Journal

Thousand Oaks-based immunotherapy company Atara Biotherapeutics Inc., which is attempting to develop drugs from a T-cell platform to treat patients with cancer and autoimmune diseases, suffered a major…

Read more Atara Makes Second Try With FDA – Los Angeles Business Journal